XML 30 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
Earnings (Loss) Per Share
6 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share

Earnings (Loss) Per Share

Basic earnings (loss) per share is computed on the basis of the weighted average number of shares of common stock outstanding during the applicable period. Diluted earnings per share is computed on the basis of the weighted average number of shares of common stock plus the potential dilutive common shares outstanding during the applicable period using the treasury stock method. Potential dilutive common shares include outstanding stock options and unvested restricted stock awards.

A reconciliation of the components of the basic and diluted per-share computations follows (in thousands, except per share amounts):

 

 

Three Months Ended

 

 

 

December 31,
2023

 

 

January 1,
2023

 

 

 

Net Income

 

 

Shares

 

 

Per-Share Amount

 

 

Net Loss

 

 

Shares

 

 

Per-Share Amount

 

 

Basic earnings (loss) per share

$

1,022

 

 

 

3,976

 

 

$

0.26

 

 

$

(1,839

)

 

 

3,927

 

 

$

(0.47

)

 

Stock option and restricted
   stock awards

 

 

 

 

22

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share

$

1,022

 

 

 

3,998

 

 

$

0.26

 

 

$

(1,839

)

 

 

3,927

 

 

$

(0.47

)

 

 

 

Six Months Ended

 

 

December 31,
2023

 

 

January 1,
2023

 

 

Net Income

 

 

Shares

 

 

Per-Share Amount

 

 

Net Loss

 

 

Shares

 

 

Per-Share Amount

 

Basic earnings (loss) per share

$

5,187

 

 

 

3,962

 

 

$

1.31

 

 

$

(1,714

)

 

 

3,913

 

 

$

(0.44

)

Stock option and restricted
   stock awards

 

 

 

 

24

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per share

$

5,187

 

 

 

3,986

 

 

$

1.30

 

 

$

(1,714

)

 

 

3,913

 

 

$

(0.44

)

 

The calculation of earnings (loss) per share excluded 49,595 share-based payment awards as of December 31, 2023 and 125,871 share-based payment awards as of January 1, 2022 because their inclusion would have been anti-dilutive.